Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Jun 30, 2025 | FY 2024Jun 30, 2024 | FY 2023Jun 30, 2023 | FY 2022Jun 30, 2022 | FY 2021Jun 30, 2021 |
|---|---|---|---|---|---|
| Total Revenue | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | -- | 624.00 | 784.00 | 976.00 | 548.00 |
| Gross Profit | -- | -624.00 | -784.00 | -976.00 | -548.00 |
| Selling General And Administration | -- | 711,778 | 1.3M | 2.3M | 1.0M |
| General And Administrative Expense | -- | 448,992 | 926,911 | 2.0M | 1.0M |
| Other Operating Expenses | -- | 4.5M | 8.7M | 9.9M | 3.0M |
| Operating Expense | -- | 5.2M | 10.0M | 12.1M | 4.0M |
| Operating Income | -- | -5.2M | -10.0M | -12.1M | -4.0M |
| EBIT | -- | -5.2M | -10.0M | -12.1M | -4.0M |
| Interest Income | -- | 72,867 | 109,915 | 49,610 | 13,091 |
| Interest Income Non Operating | -- | 72,867 | 109,915 | 49,610 | 13,091 |
| Net Interest Income | -- | 72,867 | 109,915 | 49,610 | 13,091 |
| Other Income Expense | -- | 4.1M | -73,292 | -174,938 | 197,601 |
| Other Non Operating Income Expenses | -- | -- | -- | -- | 64,476 |
| Special Income Charges | -- | -72,910 | -21,016 | 28,468 | 0.00 |
| Gain On Sale Of Security | -- | 4.3M | -52,276 | -203,406 | 133,125 |
| Earnings From Equity Interest | -- | -171,977 | 0.00 | -- | -- |
| Pretax Income | -- | -1.0M | -9.9M | -12.3M | -3.8M |
| Tax Effect Of Unusual Items | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -- | -1.0M | -9.9M | -12.3M | -3.8M |
| Net Income From Continuing Operation Net Minority Interest | -- | -1.0M | -9.9M | -12.3M | -3.8M |
| Net Income Including Noncontrolling Interests | -- | -1.0M | -9.9M | -12.3M | -3.8M |
| Net Income Common Stockholders | -- | -1.0M | -9.9M | -12.3M | -3.8M |
| Net Income | -- | -1.0M | -9.9M | -12.3M | -3.8M |
| EBITDA | -- | -5.1M | -9.9M | -12.1M | -3.9M |
| Normalized EBITDA | -- | -9.4M | -9.8M | -11.9M | -4.1M |
| Reconciled Depreciation | -- | 65,507 | 80,564 | 73,169 | 38,613 |
| Basic EPS | -- | 0.00 | -0.05 | -0.06 | -0.03 |
| Diluted EPS | -- | 0.00 | -0.05 | -0.06 | -0.03 |
| Basic Average Shares | -- | 261.7M | 219.3M | 203.9M | 142.5M |
| Diluted Average Shares | -- | 261.7M | 219.3M | 203.9M | 142.5M |
| Total Unusual Items | -- | 4.3M | -73,292 | -174,938 | 133,125 |
| Total Unusual Items Excluding Goodwill | -- | 4.3M | -73,292 | -174,938 | 133,125 |
| Tax Rate For Calcs | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -- | -5.3M | -9.9M | -12.1M | -3.9M |
| Diluted NI Availto Com Stockholders | -- | -1.0M | -9.9M | -12.3M | -3.8M |
| Gain On Sale Of Ppe | -- | 9,590 | 734.00 | 28,468 | 0.00 |
| Impairment Of Capital Assets | -- | 82,500 | 21,750 | 0.00 | 0.00 |
| Net Income Continuous Operations | -- | -1.0M | -9.9M | -12.3M | -3.8M |
| Net Non Operating Interest Income Expense | -- | 72,867 | 109,915 | 49,610 | 13,091 |
| Other Gand A | -- | 330,058 | 304,115 | 326,283 | 494,655 |
| Reconciled Cost Of Revenue | -- | 624.00 | 784.00 | 976.00 | 548.00 |
| Salaries And Wages | -- | 118,934 | 622,796 | 1.6M | 532,086 |
| Selling And Marketing Expense | -- | 262,786 | 323,309 | 328,520 | -- |
| Total Expenses | -- | 5.2M | 10.0M | 12.1M | 4.0M |
| Line Item | FY 2025Jun 30, 2025 | FY 2024Jun 30, 2024 | FY 2023Jun 30, 2023 | FY 2022Jun 30, 2022 | FY 2021Jun 30, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | -- | 2.5M | 4.9M | 10.3M | 15.4M |
| Cash Cash Equivalents And Short Term Investments | -- | 3.0M | 5.0M | 10.5M | 15.7M |
| Other Short Term Investments | -- | 506,694 | 127,154 | 165,594 | 291,500 |
| Accounts Receivable | -- | 5,887 | 40,722 | 76,831 | 0.00 |
| Receivables | -- | 94,751 | 362,948 | 613,563 | 186,029 |
| Prepaid Assets | -- | 45,115 | 50,759 | 45,896 | 55,128 |
| Current Assets | -- | 3.2M | 5.4M | 11.2M | 15.9M |
| Gross PPE | -- | 1.3M | 1.5M | 1.5M | 1.2M |
| Accumulated Depreciation | -- | -235,763 | -199,008 | -133,672 | -85,294 |
| Net PPE | -- | 1.0M | 1.3M | 1.4M | 1.1M |
| Investments And Advances | -- | 3.9M | 0.00 | -- | -- |
| Long Term Equity Investment | -- | 3.9M | 0.00 | -- | -- |
| Total Non Current Assets | -- | 4.9M | 1.3M | 1.4M | 1.1M |
| Total Assets | -- | 8.1M | 6.7M | 12.5M | 17.0M |
| Payables And Accrued Expenses | -- | 264,289 | 1.4M | 1.7M | 646,151 |
| Current Liabilities | -- | 264,289 | 1.4M | 1.7M | 646,151 |
| Total Non Current Liabilities Net Minority Interest | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | -- | 264,289 | 1.4M | 1.7M | 646,151 |
| Common Stock | -- | 42.7M | 39.4M | 36.0M | 31.9M |
| Capital Stock | -- | 42.7M | 39.4M | 36.0M | 31.9M |
| Additional Paid In Capital | -- | 9.7M | 7.7M | 6.3M | 5.0M |
| Retained Earnings | -- | -44.7M | -43.7M | -33.8M | -21.5M |
| Common Stock Equity | -- | 7.8M | 5.3M | 10.9M | 16.4M |
| Stockholders Equity | -- | 7.8M | 5.3M | 10.9M | 16.4M |
| Total Equity Gross Minority Interest | -- | 7.8M | 5.3M | 10.9M | 16.4M |
| Total Capitalization | -- | 7.8M | 5.3M | 10.9M | 16.4M |
| Net Tangible Assets | -- | 7.8M | 5.3M | 10.9M | 16.4M |
| Tangible Book Value | -- | 7.8M | 5.3M | 10.9M | 16.4M |
| Working Capital | -- | 2.9M | 4.0M | 9.5M | 15.3M |
| Invested Capital | -- | 7.8M | 5.3M | 10.9M | 16.4M |
| Share Issued | -- | 286.8M | 229.1M | 214.2M | 199.4M |
| Ordinary Shares Number | -- | 286.8M | 229.1M | 214.2M | 199.4M |
| Accrued Interest Receivable | -- | 17,082 | 82,131 | 44,812 | 0.00 |
| Investmentsin Associatesat Cost | -- | 3.9M | 0.00 | -- | -- |
| Investmentsin Joint Venturesat Cost | -- | 3.9M | 0.00 | -- | -- |
| Machinery Furniture Equipment | -- | 312,512 | 351,674 | 336,221 | 189,098 |
| Other Equity Interest | -- | 119,212 | 1.8M | 2.4M | 1.0M |
| Other Properties | -- | 955,737 | 1.1M | 1.2M | 970,102 |
| Taxes Receivable | -- | 71,782 | 240,095 | 491,920 | 186,029 |
| Line Item | FY 2025Jun 30, 2025 | FY 2024Jun 30, 2024 | FY 2023Jun 30, 2023 | FY 2022Jun 30, 2022 | FY 2021Jun 30, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -- | -5.9M | -9.4M | -10.0M | -3.1M |
| Cash Flow From Continuing Operating Activities | -- | -5.9M | -9.4M | -10.0M | -3.1M |
| Depreciation And Amortization | -- | 65,507 | 80,564 | 73,169 | 38,613 |
| Depreciation Amortization Depletion | -- | 65,507 | 80,564 | 73,169 | 38,613 |
| Stock Based Compensation | -- | 10,656 | 367,960 | 1.4M | 412,708 |
| Change In Working Capital | -- | -885,485 | 5,649 | 599,265 | 398,815 |
| Change In Receivables | -- | 268,197 | 250,615 | -427,534 | -90,605 |
| Change In Payables And Accrued Expense | -- | -1.2M | -240,103 | 1.0M | 530,759 |
| Other Non Cash Items | -- | -5.0M | 79,780 | 72,193 | -116,976 |
| Capital Expenditure | -24,671 | -- | -36,947 | -313,051 | -493,472 |
| Purchase Of PPE | -- | 0.00 | -36,947 | -225,446 | -204,067 |
| Net PPE Purchase And Sale | -- | 30,390 | 20,120 | -143,446 | -204,067 |
| Purchase Of Business | -- | -1.00 | 0.00 | -- | -- |
| Investing Cash Flow | -- | 30,389 | 20,120 | -231,051 | -493,472 |
| Cash Flow From Continuing Investing Activities | -- | 30,389 | 20,120 | -231,051 | -493,472 |
| Issuance Of Capital Stock | -- | 3.7M | 4.1M | 5.0M | 9.5M |
| Net Common Stock Issuance | -- | 3.7M | 4.1M | 5.0M | 9.5M |
| Financing Cash Flow | -- | 3.5M | 3.9M | 5.2M | 16.3M |
| Cash Flow From Continuing Financing Activities | -- | 3.5M | 3.9M | 5.2M | 16.3M |
| Changes In Cash | -- | -2.4M | -5.4M | -5.1M | 12.7M |
| Beginning Cash Position | -- | 4.9M | 10.3M | 15.4M | 2.7M |
| End Cash Position | -- | 2.5M | 4.9M | 10.3M | 15.4M |
| Free Cash Flow | -3.5M | -5.9M | -9.4M | -10.3M | -- |
| Amortization Cash Flow | -- | 624.00 | 784.00 | 976.00 | 548.00 |
| Amortization Of Intangibles | -- | 624.00 | 784.00 | 976.00 | 548.00 |
| Asset Impairment Charge | -- | 82,500 | 21,750 | 0.00 | -- |
| Capital Expenditure Reported | -24,671 | -- | 50,067 | -87,605 | -289,405 |
| Change In Prepaid Assets | -- | 5,644 | -4,863 | 9,232 | -41,339 |
| Common Stock Issuance | -- | 3.7M | 4.1M | 5.0M | 9.5M |
| Depreciation | -- | 65,507 | 80,564 | 73,169 | 38,613 |
| Earnings Losses From Equity Investments | -- | 171,977 | 0.00 | -- | -- |
| Gain Loss On Sale Of PPE | -- | -9,590 | -734.00 | -28,468 | 0.00 |
| Net Business Purchase And Sale | -- | -1.00 | 0.00 | -- | -- |
| Net Income From Continuing Operations | -- | -1.0M | -9.9M | -12.3M | -3.8M |
| Net Other Financing Charges | -- | -190,742 | -199,886 | -73,000 | -468,756 |
| Net Other Investing Changes | -- | -- | -- | -87,605 | -289,405 |
| Operating Gains Losses | -- | 162,387 | -734.00 | -28,468 | -- |
| Proceeds From Stock Option Exercised | -- | -- | 0.00 | 262,690 | 7.3M |
| Sale Of PPE | -- | 30,390 | 57,067 | 82,000 | 0.00 |
| Unrealized Gain Loss On Investment Securities | -- | 692,059 | 52,276 | 203,406 | -80,625 |